LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of simulation and modeling software to the pharmaceutical industry, has announced that one of its acquisition opportunities is no longer under consideration, while two new opportunities have appeared and are under investigation.
